Author

Elaine Yee

Alnylam Pharmaceuticals (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Chris GriffithsiD· 1 shared Dan MasoniD· 1 shared Daniel G. MacArthuriD· 1 shared David A. van HeeliD· 1 shared David V. Erbe· 1 shared Debbie A. LawloriD· 1 shared Devin OglesbeeiD· 1 shared Eric B. FaumaniD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Chris GriffithsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Deep phenotyping of a healthy human HAO1 knockout informs therapeutic development for primary hyperoxaluria type 1.

Tracy L. McGregor, Karen A. Hunt, Elaine Yee, Dan Mason, Paul Nioi, Simina Ticau, Marissa Pelosi, Perry R Loken, Sarah Finer, Debbie A. Lawlor, Eric B. Fauman, Qin Qin Huang, Chris Griffiths, Daniel G. MacArthur, Richard C. Trembath, , David A. van Heel

The paper identifies a healthy individual with complete HAO1 knockout, showing normal oxalate levels but elevated glycolate, supporting the safety of HAO1 inhibition for PH1 therapy.

eLife · Mar 24, 2020Peer-reviewedGenetics